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Abstract 
Part 1 revisited developments in lipid and surfactant self assembly over the past 40 
years [1]. New concepts emerged. Here we explore how these developments can be 
used to make sense of and bring order to a range of complex biological phenomena. 
Together Part 1, this contribution is a fundamental revision of intuition at the 
boundaries of Colloid and Science and Biological interfaces from a perspective of 
nearly 50 years. 
We offer new insights on a unified treatment of self assembly of lipids, surfactants 
and proteins in the light of developments presented in Part 1. These were in the 
enabling disciplines in molecular forces; hydration, oil and electrolyte specificity; and 
in the role of non Euclidean geometries—across the whole gammut of physical, 
colloid and surface chemistry, biophysics and membrane biology and medicine. 
It is where the early founders of the cell theory of biology and the physiologists 
expected advances to occur as D’Arcy Thompson predicted us 100 years ago.  
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PART 2 - COLLOIDS AND SURFACE SCIENCE MEET REAL 
BIOINTERFACES 
 
1. Introduction 
It is exactly 100 years since the publication of D’Arcy Thompson’s book On Growth 
and Form [2]. We learn from him that Kant said of the chemistry of his day and age 
that it was a science, but not Science – “eine Wissenschaft, aber nicht Wissenschaft” - 
for that the criterion of a true science lay in its relation to mathematics. 
On the other hand Auguste Comte said that if chemistry ever were to rely on 
mathematics it would cause a rapid degeneration of that science. Whence these two 
philosophers derived their authority is unclear. Neither ever did an experiment. Kant 
spent his whole life walking around Königsberg which must have been awful for him, 
and Comte was a social scientist. The quotations may be out of context. But the 
opposing views serve to focus the mind on a venerable issue posed by Thompson: 
How to bridge the divide between the physical and biological sciences?  
Again, from Thompson, Emile Du Bois-Reymond said 100 years after Kant that 
chemistry would only reach the rank of science when – in modern language – it 
derived its laws from statistical mechanics, using molecular forces.  
In Part 1 we outlined new concepts in lipid and surfactant self assembly over the past 
40 years [1]. Here we apply these to make sense of some biological phenomena.  
 
2. A Miscellany of Interactions of Surfactant, Polycation and Lipid Membranes 
The complexity of real biological membranes - rather than membrane mimetic lipid 
models - is obvious. However some inferences on mechanisms of action can still be 
drawn from the latter. 
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Some provide useful hints for drug applications. Some examples: 
 
2.1. Bacteriocidal action of Cationic Surfactants 
Cationic surfactants as bacteriocides have wide usage, from hospitals to households - 
toothpaste, washing detergents, skin care, eye lubricants and for a time even 
spermicides! Their action can be understood in terms of changes in membrane 
interfacial curvature induced by their adsorption. At the cmc (in physiological saline) 
the single chained surfactant (p ~ 1/3) adsorbs into the double chained lipid 
membrane (p ~ 1). The mixed surfactant then has peffective < 1. The membrane is 
destroyed [3]. 
The argument is not sufficient. If that were the whole story then an anionic or non-
ionic surfactant of the same (hydrophobic) chain length could also do the job just as 
well. They do not. The example in Part 1 on sulphate DDAB microemulsions shows 
explicitly that the hydration of sulphate ion and that of the didodecyl 
dimethylammonium terminal group are incompatible [1,4]. 
Since the terminal groups of a phosphatidylcholine lipid is much the same as DDAB, 
a common surfactant like SDS can not adsorb. Similarly for nonionic surfactants. The 
head group hydration is just not compatible. 
This difference in specific hydration seems at the root of the superactivity of sulphate 
in the common enzyme horseradish peroxidase [5]. The toxicity of specific ions like 
La(III) and Co(III) and their much different toxicity can be traced to similar lipid head 
group hydration interactions [6]. 
 
2.2. Immunosuppression of Cationic Surfactants 
At concentrations far below the cmc, cationic surfactants behave as potent 
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immunosuppressants. This discovery in 1981 was very surprising. Since the 
surfactants are so widely used in first world countries the implications are as 
enormous and ignored. They are more effective as immunosuppressants than the once 
used drugs of choice for organ transplants. The mechanism has been identified and 
confirmed in in vitro mixed lymphocyte culture experiments, in vivo mouse thyroid 
rejection studies and in human models.  
Here is how they work: Below the cmc the surfactant does not disrupt the membranes 
of T-cells that trigger the immune response. Uptake and its chain length dependence 
follows a Langmuir isotherm. That is, the process is physical chemistry. 
After adsorption the cationic surfactant flips over to the inner side of the membrane 
which contains anionic phosphatidylserine lipids. The cationic surfactant neutralises 
its negative charge. Consequently the membrane bound calcium drops. Calcium is 
crucial to structure of the major histocompatibility transmembrane protein complex 
responsible for recognition of antigens. The immune response is switched off [7,8]. 
 
2.3. Local Anaesthesia  
Another example that illustrates the interplay between lipids and an actual medical 
response is the action of local anaesthetics. 
The most typical is lidocaine and similar molecules. They have a large bulky cationic 
head group and a relatively short hydrophobic portion. When injected in excess in a 
localised region, the law of mass action forces the hydrophobic tail to anchor in the 
the lipid region of a nerve cell. 
This changes the membrane surface charge and its potential. So the propagation of an 
electrical signal is switched off. After a time the lidocaine leaks out. 
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This picture is oversimplified. But basically that is it. The hydration of the bulky head 
group has to be compatible with that of the membrane phospholipids. 
Similar effects are achievable with cationic surfactants, with some venoms, in snakes, 
jellyfish, toads, and octopuses that use (polycationic) polymeric poisons [3]. 
 
2.4. General Anaesthesia and Alkane Poisoning 
To anticipate the more detailed intricate account of section 4 on this problem we refer 
to a potted history of earlier ideas on the topic [9]. From the perspective of a physical 
chemist, or an intelligent physiologist the literature ideas are crude.  
 Conceptually simpler ideas of how these phenomena occur emerge in the light of 
recent developments in self assembly. The key to it is this: 
As discussed in Part 1, just as there are many phases of lipids possible in three 
dimensions, so too there are in two dimensions (mesh phases). This is so also for the 
two dimensional world of biomembranes. 
Par excellence is this so for lipid-protein-cholesterol mixtures that form real 
membranes [10]. Transitions from one form to another occurs with extravagant ease. 
That is, not too much energy is required to trigger such transitions. Such lipid 
transitions (section 4) are integral to the transmission of the nerve impulse. 
That such lipid-protein-cholesterol phase transitions must occur follows if admit cubic 
and mesh phases (noneuclidean geometries) into the pantheon of allowed phases [11]. 
This is new. Literature discussion of mechanisms of how general anaesthesia operate 
ignore these structures. So the literature ignores the source of the mechanism it is 
trying to explain. It is therefore incomprehensible [12,13]. 
The modern view envisages anaesthesia as a process where the active molecule 
accumulates in the hydrophobic region of the neuronal membrane, directly interacts 
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with the membrane lipids, and alters the fluidity, the curvature and phase structure of 
the bilayer. Eventually this change affects the conformation and functional 
performances of ion channels, receptors and more in general of transmembrane 
proteins [13-18]. In 1988, Larsson first introduced this hypothesis of an anaesthetic 
induced change of the membrane phase state. The hypothesis implied that the 
transmission of the nervous impulse involved not just ion channels. It was rather 
driven by reversible lipid phase changes that propagated, coupled to, and triggered 
opened and closed ion channels. So an inhalation anaesthetic- induced lipid phase 
change would be too extreme to allow the functioning of ion channels [3,19]. 
A moment of reflection gives that hypothesis support. There was no other means by 
which channels opened and closed except by Hodgkin–Huxley equations that simply 
characterise the process, but say nothing of mechanism. We later deal with later 
presently popular refinements proposed to control the effects of anaesthetics.  
The origins of anaesthetic action may well be manyfold, but such a conclusion 
ignores the lipid phase changes that physics demands must be integral to the process 
[20]. 
We can go further. For in any case lipid rearrangement i.e. a change in the curvature 
(surfactant parameter, p) of the bilayer must be induced by the uptake of a 
hydrophobic anaesthetic. This does not conflict with a modification of the hydration 
of the lipid head groups. Indeed it is a necessary consequence [9]. 
For example, lidocaine hydrochloride changes the phase transitions of lipid 
dispersions, by inducing a lowering in the transition or pre-transition temperature in 
DPPC or DHPC bilayers [21]. This effect depends essentially on the hydrophobicity 
of the anaesthetic. Adsorbed into the lipid bilayer it induces the corresponding change 
[9,22]. 
 8 
One outstanding issue is that xenon is a most effective anaesthetic, widely used in the 
Netherlands [23]. Pauling suggested that its potency was related to the formation of 
clathrates [24]. Why, he did not say. Possibly since xenon has a high polarisability (its 
static polarisability is larger than 4 Å3 [25]) and therefore can interact via dispersion 
self free energy to partition into the lipid hydrocarbon chains. That could probably be 
established by looking up its solubility in oils. Recently, it was shown that xenon can 
modify the domain structure in “lipid raft” membranes [26]. 
If opening and closing of channels, propagation of the nervous impulse are coupled to 
lipid phase changes, it is of no consequence whether membrane phase state is 
perturbed by adsorption of an anaesthetic molecule at the hydrophilic or hydrophobic 
side, of the interface. Both will change curvature. So the debate is empty. Pauling was 
probably right for xenon as patients have little side effects.  
When the anaesthetic is at least partly polar, its activity has been supposed to be at the 
water-membrane interface, and its specific action mediated by the release of hydration 
water molecules that are strongly bound to the polar head groups [27].  
This is obvious. Membrane curvature and lipid phase state changes if hydration 
changes. That effect has been confirmed by spectroscopic experiments on halothane 
(F3C-CBrClH), a typical inhalatory partially polar anaesthetic (the dipole moment is 
about 2 D [28]), in lamellar phases of DMPC [29,30]. 
A most dramatic simple illustration of lipid phase changes induced by anaesthetics is 
illustrated by isoflurane (F3C-CHCl-O-CHF2). After exposure to the gas, the 
isoflurane molecule is taken up in the hydrophobic region of the membrane and swells 
the hydrophobic core. This means the required lipid transition for conduction of the 
impulse is no longer possible. Fluorocarbons and hydrocarbons are structurally 
incompatible [31,32]. So after a time the fluorocarbon is released and the membrane 
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goes back to its normal resting state.  
This can be seen with a simple experiment (K. Larsson and B. W. Ninham, 
unpublished results): Bubble isoflurane gas through a suspension of 
phosphatidylcholine multilayer vesicles. (They appear as a white emulsion and are 
easily made by sonication). After a few minutes the suspension transits to a clear 
viscous cubic phase which proves the point. If left for 15 minutes the isoflurane which 
resides in the hydrophobic membrane core comes out. The system returns to its 
original state. 
What can be drawn from that experiment is inevitable. 
The change in lipid bilayer curvature and phase state induced by adsorption of the 
anaesthetic can not be disputed. If a corresponding change does not occur in real 
biological membranes one has to ask why. It is clearly the key factor underlying the 
phenomenon. 
The structure of nerve membranes is much more complex than an assumed lipid 
bilayer, for example a multilayer for which there is some evidence [33]. But the same 
conclusion on coupling of lipids to channels remains. 
The same accounts for the invidious effects of octane and other hydrocarbons on the 
brain (petrol sniffing). Hydrocarbons are miscible with lipid chains and impossible to 
remove. The “high” achieved by sniffing analogous to many other recreational drugs 
induces a permanent state of idiocy or sub optimal brain performance [34]. 
Again, the perturbation of the interfacial hydration layer in the biological membrane 
may result in conformational changes of the membrane proteins. 
 
3. More Structural Changes Inside Lipid Bilayers 
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Some other biological and physiological functions and their linkage to physical 
chemistry will now be discussed. For these functions it will again be clear that 
molecular reorganisations in the membrane hydrophobic regions that dictate 
structures and phase transition mechanisms together determine function. One essential 
factor here is the relation between the rigid cholesterol skeleton to the liquid-like 
disordered hydrocarbon chains of the bilayer. Another trigger of structural changes 
lies with the bilayer spanning peptide chains of membrane proteins. These are usually 
in an α-helical conformation with hydrophobic side chains. Very minor 
conformational changes of the hydrocarbon chain geometry can trigger transitions 
into periodically curved (mesh phase) bilayers. 
 
3.1. Cubic Biomembranes  
A major inhibition to progress in bridging the physical–biological sciences divide has 
been a dispute for over 40 years on the complex structures of lipid phases. The French 
School under Luzzatti vigorously advocated a set of structures that was impossible. 
The definitive proof of the existence of cubic bilayer phases, a then completely new 
concept in structure, emerged from x-ray studies on the monolein-water system [35]. 
These structures are periodically curved bilayers with zero average curvature. (They 
are termed cubic phases because their symmetry is the same as that of ordinary cubic 
crystals) [3,11]. They are quite unlike asymmetrical lipid vesicle (or multibilayer) 
liposomes. Here the outer normal curvature of a bilayer is positive. The inner 
curvature is negative (see Section 2.3 of Part 1) [1]. In cubic phases the inner lipid 
frustration depicted in Figure 2 of Part 1 is relieved for cubic phases by having lipids 
arranged so that curvature in one direction cancels that in the orthogonal direction 
everywhere. The net curvature is everywhere zero, i.e., the same as that of a planar 
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bilayer. The gaussian (product of normal curvatures) varies continuously over the 
surface. The number of such bicontinuous (non Euclidean) geometric shapes possible 
is very large [11,36]. They are now known to occur in solid state physics as surfaces 
along which electrons transit. The most well known structures occur with zeolites. 
They are hard to recognise with lipids because their symmetry allows 
misidentification without exceptional care, e.g. as hexagonal phases. Similar, myriad 
such structures occur in Nature in symmetric and asymmetric regular two dimensional 
arrays, e.g. in the bark of trees and drying of clay surfaces [36,37]. 
Their distinguishing special characteristic is that they can transform from one form to 
another with extravagant ease by cooperative rearrangements. 
These surfaces, the P (primitive), D (diamond) and G (gyroid) are illustrated in Figure 
1.  
 
Fig. 1. Schwarz' P (primitive), D (diamond) and G (gyroid) surfaces. The blue and 
purple colours show the two distinct channels of the surfaces. Reproduced from Ref. 
38 with permission of the International Union of Crystallography, Copyright 2013. 
 
The aqueous monolein system exhibits two cubic phases.  
There are three periodic minimal surface cubic phase structures. They are the gyroid 
(G), the diamond (D) and the primitive (P) phase. They correspond to FCC, BCC and 
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simple cubic packing of spheres. If we like they can be envisaged as the dual of these 
sphere packings with the bilayer wrapping around the space between the spheres. The 
gyroid structure is formed above the swelling limit of the lamellar liquid-crystalline 
phase, and at increased water content, the diamond type of phase is formed as shown 
in Figure 1. 
The third type of cubic phase, described by the primitive minimal surface, has been 
observed in a range of lipid systems incorporating proteins, e.g. the monoolein-water 
system with cytochrome c at high water content [39] and lysozyme in 
monoolein/distearoyl phosphatidylglycerol mixed systems [40]. The incorporation of 
a protein into the aqueous channels of a bicontinuous cubic phase induces both 
changes in the head group region and a higher conformational order in the acyl chain 
region [41]. The same cubic phases occur in the ternary phase diagrams of cationic 
surfactant-water-oil microemulsions systems discussed above [42]. The most common 
structures with oil-water-surfactant mixtures are ubiquitous, disordered and 
bicontinous; if we like disordered cubic phases of constant, not zero, average 
curvature. An important work relevant to our discussion of lung surfactants below is 
reported in Ref. 43. The transition in microstructure from disordered (or ordered) 
monolayers of surfactants dividing oil and water to bilayers involves complex 
topological rearrangements unravelled in that paper. 
Many other papers dealing with the matters of this section are collected together in 
Ref. 44. See also Refs. 11 and 36. 
 
3.2. Cubosomes 
Monoolein, a single chained lipid used as a model system to study phase behavior, is 
widely exploited for drug delivery. A phase transition from a closed multilamella state 
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to an open bicontinuous cubosome can take place with change in temperature or 
physico-chemical conditions in a patient. A drug can be incorporated and delivered in 
the lamella liposomes. Then the transition to an open bicontinuous state (a cubosome) 
is ideal for in situ delivery [37]. This technique was developed by Kåre Larsson. 
Colloidal particles of the (bicontinuous) cubic phase, termed cubosomes [38], can 
easily be made for optimal delivery. The cubosome consists of several unit cells with 
a closed structure formed by a single curved lipid bilayer. The inside space is 
separated by the bilayer to form two separate systems of water channels.  
Archaebacteria are found under extreme conditions, like the base of underwater 
volcanic mountains, where they grow at high heat, large salinity and at very low pH. 
Their membrane consists of chains with methyl branches instead of double bonds. 
There are ether-linked polar head groups at each side of the two chains without any 
end group opening in the middle (bolaform surfactants) [45]. Luzzati with coworkers 
have shown that these membrane lipids form cubic phases under physiological 
conditions [46]. 
An ultrastructure that resembles a cubosome was described early on by Gunning from 
electron microscopy analysis. It is formed by the thylakoid membranes. They 
represent a vegetative state of thylakoid membrane stacks termed prolamellar bodies 
in plants. They form, for example, during winter without photosynthesis. The 
structure was shown to be consistent with the diamond type of cubosome [47]. Later 
Yuru Deng discovered a similar vegetative state in mitochondria of amoebae. It was 
found to be formed reversibly at starvation [48]. 
Evidence for cubic membranes as possible functional states of biomembranes were 
reported in several ultrastructural descriptions in the literature [49]: 
1. The dendritic organ grandular cells. 
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2. The double membranes in some Gram-negative bacteria. 
3. The Gram positive Streptomyces hygroscopicus. 
4. The inner and outer membranes of secreted milk fat globules. 
A large number of cytomembranes exhibiting cubic membranes have been identified 
[11,50]. Most involved diseased conditions.  
Present opinion is that it is unlikely that a symmetric bilayer can exhibit an active 
single-bilayer structure (cubosome) in biological systems. Membrane asymmetry is 
supposed to be critical for a functional membrane. The asymmetry is maintained by a 
phospholipid transferase. This maintains the serine group of the phosphatidylserine 
head group exposed towards the inside. When serine occurs at the outside, it indicates 
that the transferase is not working, and this is a marker for apoptosis (programmed 
cell death) [50,51]. (This “accepted” explanation of membrane asymmetry, 
maintained by an enzyme, begs the question of how it works). If in such a situation 
symmetric membranes occur, however, it may be that they provide the least biological 
disturbances if they are condensed into the different cubic membrane assemblies 
identified so far [11,50]. The opinion contrasts with the existence of Archaebacteria 
and extremophiles. 
A different point of view emerges from the considerations of Section 2.3 Part 1 on 
vesicles.  
There we saw that with either single walled or multilamellar liposomes the curved 
membrane is necessarily asymmetric. Below a certain radius, typically 100 nm for 
most lipids, the curved bilayer is forbidden by geometry. The interior can however 
easily collapse into a cubic phase. The whole structure, a state of supraself-assembly, 
a bicontinuous cubic organelle surrounded by a protective layer of bilayers is a 
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necessary consequence of local packing conditions of lipid chains. If such structures 
do not form one has to ask why they do not. 
The channel sizes of simple – one component - lipid cubic phases are typically around 
3 nm. Those water channels for most cubic membrane assemblies observed in living 
systems are much larger, around 100 nm. As for cubic phases it is very challenging to 
obtain lipid based cubosomes with a channel diameter larger than 10 nm. This can be 
achieved by adding cholesterol and charged lipids [52]. With the large channel objects 
this indicates that they might be formed by a mechanism like double diffusion, 
Gibbs–Marangoni hydrodynamic processes, but in biological systems there are also 
protein components that promote the formation of larger channel sizes.  
A less complex explanation for the formation of large channel aggregates might be 
seen if we consider the microemulsions of Part 1. There we saw that bicontinous 
structures of widely varying size form as a result of global packing constraints. But 
water structure (hydration) features as a hidden parameter. 
 
3.3. The Lung Surface  
A prime example of bilayer structural transformation induced by molecular 
rearrangements inside the bilayer is the mammalian lung surface. The lung surfactant 
is a lipid-protein complex with about 90% lipid and 10% protein. This bounds the 
surface of the alveoli. It forms an organised coherent phase. The structure is 
remarkably similar to the minimal surface membrane assemblies above. The physical 
properties of this state of self organisation has direct implications for lung function 
and pathological conditions involving the alveolar surface.  
The lipid fraction of the lung “surfactant” is dominated by dipalmitoyl- 
phophatidylcholine (DPPC) with phosphatidylglycerol (PG) as the second most 
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abundant component (DPPC:PG ratio 9:1). In addition it contains about 10% 
cholesterol [53]. There are two hydrophilic proteins in the surfactant. These are 
termed SP-A and SP-D. Then there are two extremely hydrophobic proteins; SP-B 
and SP-C [53]. The proteins are essential to lung function. Numerous ultrastructural 
studies had indicated some organisation in the subphase. A common observation was 
that of a periodic arrangement of planar layers. These were assumed to be lipid 
bilayers. Accompanying that apparent arrangement were bilayers along two 
perpendicular directions. This texture was labeled tubular myelin. It had been 
assumed to form a depot for a monolayer at the air/water interface. The addition of 
different combinations of the constituent proteins SP-A, SP-B and SP-C to extracted 
lung phospholipids have been studied. They showed that a combination of SP-A and 
SP-B is needed in order to form tubular myelin.  
The conditions that the lung surface has to satisfy are stringent. It has to rearrange and 
expand vastly, in the process expelling water and CO2. It then takes up oxygen at 
essentially zero work, and folds back. It repeats this several times a minute and does 
so for the decades long life of an individual. 
For 50 years the accepted model of the lung surface was a lipid monolayer that sits 
above an aqueous subphase. The monolayer interfacial tension of such a model would 
be far too large by orders of magnitude. Despite this, most research groups in the field 
played with monolayer models from surface chemistry. The irrelevance of such 
studies did help in acceptance of the actual surface phase model of the lung surface. 
Here is the story: The cubosomes of cell biology (Section 3.2) have membranes that 
are complex mixtures of lipids and proteins. The dimensions of the water channels, 
typically 500-1000 Å, are much larger than water channels (about 30 Å) formed by 
membrane mimetic lipids. The latter, lipid-water mixtures alone form bulk 
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equilibrium phases. These occur simply as a result of the requirement that local 
curvature (molecular packing) and global packing constraints have to be satisfied. 
Cubic membrane assemblies probably form as a result of double diffusion gradients 
set up by steady state biochemical processes. They are evidently involved in cell 
fusion and biochemical traffic, where bicontinuity confers clear, essential advantages. 
Such structures are obviously ideal candidates to do the lung surfactant job. In 1999 it 
was reported that the lung “surface”, the “air/water interface” of the alveoli, is formed 
by a surface phase organized into a periodic minimal surface structure formed by the 
surfactant lipid bilayer–protein mixture (see Figure 2) [54,55]. 
This triggered off studies embodied in a 2008 review by Pérez-Gil [56]. He concluded 
that there are different surface phases that form the alveolar surface. See also Refs. 57 
and 58 for later work. 
The alveolar surface phase first reported by Larsson et al. [59] (see Figure 2) was 
revealed by cryo-TEM studies of freshly opened alveolar surfaces of rabbit lungs, by 
transfer of the surface layer to the grid and immediately freezing the structure 
(without ice crystal formation) [59]. 
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Fig. 2. The first reported complex bicontinuous structure formed by lung surfactants. 
Reprinted from Ref. 60 with permission from Elsevier. Copyright 2014.  
 
The dimensions were in agreement with a well-known ultrastructure in the alveolar 
region termed tubular myelin (TM). It had been assumed to consist of two intersecting 
stacks of bilayers forming a tubular network. This was regarded as a storage silo of 
surfactant bilayer and the water-soluble protein SP-A. The observations from cryo-
TEM showed how a uniform and coherent phase could form by a single bilayer 
without self-intersections based on a known periodic minimal surface lipid bilayer 
termed CLP (crossed layers of parallel) minimal surface. The structure is shown in 
Figure 3.  
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Fig. 3. The bilayer of TM/CLP is seen in two adjacent cross-sections (A and B), these 
cross-sections overlapping (C), and finally in a calculated structure (D) of the 
corresponding minimal surface (using Mathematica and adopting the nodal surface 
approximation). Reproduced from Ref. 59 with permission of Springer. Copyright 
2002. 
 
The driving force behind the transition from the multilamellar surface phase and 
CLP/TM is a tendency of the water soluble octadecameric protein SP-A to associate 
(perhaps electrostatically) with the SP-B complex. Two SP-A octadecamers are 
associated at their collagenous ends and such dimers span the diagonals of the tubuli. 
The possibilities of other minimal surface conformations have been analysed and only 
one other alternative appeared possible: a tetragonally deformed cubic P-surface [60]. 
However, mainly due to its mechanical properties, it seemed a less likely candidate. 
The three-dimensional character of the TM/CLP structure and its ability to be 
viscoelastically deformed provides a mechanism behind reduction of the work 
required for breathing. The physiological aqueous lipid-protein lining of the alveoli 
forms the lung “surfactant” region that controls the transport of O2 in from, and CO2 
out to the air. Based on model studies it is tempting to assume the presence of 
microbubbles of carbon dioxide on expulsion as such bubbles are inhibited from 
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fusing at physiological salt concentration [61]. The inhomogenous nature of the 
boundary region may itself be the source and sink of the rearrangements in structure 
that allow diffusion. Calcium ion is known to interact with the phosphatidylcholine 
head groups. This can change curvature and unzip the folded bilayer pegged together 
by the proteins so exposing hydrophobic monolayers for oxygen uptake. The 
mechanism by which such a topologically difficult process can occur has been 
elucidated in the parallel case of tetradecane-water emulsions (see Part 1) by Hyde et 
al. [43]. 
 
3.4. Lipid Rafts and Caveolae 
A lipid molecular packing transition is induced in phospholipid bilayers by 
cholesterol. In a neutron diffraction study of DMPC-cholesterol aqueous phases, 
Mortenssen et al. in 1988 reported that it induces a unique kind of phase transition 
within the bilayer. The result is ordered strips that are cholesterol-rich. These alternate 
with cholesterol-poor less ordered strips. These are called L(o) and L(d) respectively 
[62]. Such microsegregation is a general phenomenon of statistical mechanics for 
solids and liquid crystals. It is a property of alloys and occurs for any two component 
system [63]. 
Another topographic alternative is the formation of islands of L(o)-conformation of 
the bilayer within an L(d) environment. These so-called “lipid rafts” are regions 
where membrane embedded proteins are localized. Such regions might also be curved 
into so-called caveolae (little caves) due to special proteins present. 
The phase separation of cholesterol-rich regions L(o) for DPPC, one of the major 
lipids in lung surfactants, starts at about 8% mol/mol cholesterol in the bilayer, and 
the two-phase region ends at about 20% mol/mol cholesterol [64]. This segregation 
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and X-ray diffraction effects at physiological temperatures have been demonstrated in 
lung surfactant bilayer systems [55,65]. 
The phenomenon will reappear in connection with the nerve signal conduction in 
Section 5. 
 
3.5. Fats, Oils, Phospholipids and Digestion 
Phase transformations in lipids are central to gastrointestinal digestion. The processes 
involve absorption from emulsions - via micellar solutions - to lipoproteins in the 
circulation. Oil and fat components work with these lipid phase transformations and 
bile salts via global packing changes to produce a remarkably efficient machinery. 
Bile salts are very different kinds of surfactants and different from lipids in possessing 
very rigid structures. The field is so vast and technical that we leave this story to Refs. 
66-70. 
 
4. Signaling Systems within the Bilayer 
4.1. Axon Pulse Propagation, Synaptic Chemical Signal Transfer 
Axon Pulse Propagation 
The classical (1952) theory of electrophysiology for nerve signal conduction is due to 
Hodgkin and Huxley [71]. It “explained” the local positive exterior electric charge of 
the axon membrane and its progression by the opening of the sodium channels. And it 
explained the relaxation to negative resting surface charge outside the membrane by 
sodium and potassium ion gradients. At least it provided a mathematical 
characterisation of the process. This became core dogma. 
Astoundingly, no mechanism was advanced until 2005 [72]. The “soliton wave theory” 
couples phase transitions known in lipid bilayers to opening and closing of ion 
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channels [73]. It also takes account of cooperative membrane protein localization into 
lipid rafts within the membrane [74]. The coupling of lipid phase transitions to ion 
channel association and transport is a necessary consequence of membrane 
constitution to condensed matter physicists. 
We will return to axon membrane signal conduction and its coupling to lipid phase 
transitions in the further discussion below of anaesthetic effects. 
Inconvenient Truths 
However satisfactory such a state of affairs appears, there is a problem. The “theory” 
rests on a foundation provided by Hodgkin-Huxley. That is an application of classical 
double layer theory of colloid science. No ion specificity or mechanism for ion 
partitioning exists. We saw in Part 1 that the attempts by Ling to explain cationic 
distribution asymmetry via Donnan equilibrium – essentially the same theoretical 
foundation - were dismissed. Ion pumps were then postulated and became part of the 
theology. When it is repaired the necessity for ion pumps is not obvious [3]. The 
inconsistency remains. The Hodgkin–Huxley foundation relies still on classical theory 
which we know is wrong! It can only be resolved once theories take account of 
Hofmeister effects [75]. 
 
4.2. Chemical Signaling at the Nerve Synapses. Vesicles and Supraaggregation  
From one axon to another the signal can be transferred via a variety of transmittor 
molecules. The different transmittor molecules affect different functions of the brain; 
e.g., for the brain to muscle, the transmittor substance is acetylcholine. 
When the spike in an axon reaches the synapse, the influx of calcium ions induces a 
mass-cooperative fusion of transmittor molecule-loaded “vesicles” at the presynaptic 
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membrane. The postsynaptic membrane will then induce a new action potential. If a 
muscle cell is targeted the actin-myosin contraction cycles are started or continued. 
The chemical signal transport over the synapses takes place under stringent time and 
signal strength control. The mechanisms are not known. But we can make a guess. 
Recall our earlier discussions of cubic membranes. And of supraaggregation with 
vesicles, the interior which contains bicontinuous cubic phases. The mass-fusion of 
vesicles may draw on such conformational changes. Calcium ions can induce fusion 
between these vesicles and simultaneously a fusion with the presynaptic membrane.  
Knowing what we expect on supraaggregation of lipids, from Section 2.3 of Part 1, 
the interior of vesicles is likely to contain cubic microphases with excess calcium for 
efficient delivery across the synapse. Such a possibility is expected on grounds 
discussed in earlier sections. It would also explain another related mystery. 
Electrical transmission of signals in the brain can be tracked over many synapses and 
large distances. This apparently leads to calcium depletion. Yet restoration to resting 
potential conditions is rapid. It seems reasonable to assume that lipid phase transitions 
associated with the conduction process can “bleb off” vesicles containing calcium 
along the axon as well as at the synaptic junction. These would act as reservoirs to 
“recharge” the axon after the signal has passed. 
In any event, whatever the complexities, several observations relevant to our thesis on 
the role of hydrocarbon lipids emerge.  
It seems that: 
1) Microphase separation into rafts that bring proteins into association occurs. It is a 
consequence of the defects induced by cholesterol. The phase separation is an 
unavoidable expectation from statistical mechanics.  
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2) The curvature due to the cholesterol-lipid mixture in a raft is necessary to allow the 
proteins to pack within the membrane. 
3) The whole process is underlaid by lipid bilayer phase transitions.  
4) Cubic microphases due to supraaggregation are necessary to effect trans-synaptic 
transfer. The open bicontinuous structures allow rapid delivery. 
All four concepts that follow as in Part 1, from local curvature and global packing 
constraints alone. These have been missing in interpretations of experiment which 
have mass-fusion of vesicles to “phase-inversion conformational changes”.  
This is a very fashionable field of research. Witness another of the ubiquitous Nobel 
Prizes in Physiology or Medicine (2013) on the machinery regulating vesicle traffic. It 
involves so-called SNARE proteins that play a role in the vesicle fusion process. 
However the role of the lipids in this process or for that matter how authority for 
direction of the process is assigned to the proteins is sufficiently arcane for us to avoid 
it. 
 
4.3. The G-protein System illustrated by the Physiology of the Olfactory System and of 
the Pheromone Activity 
4.3.1. The G-protein System 
A membrane-localized protein called a G-protein with a G-protein-coupled-receptor 
(GPCR) forms a complex signaling system in eukaryotic cells. An understanding of 
the physiology is new. (More Nobelers! R. Leifkowitz and B. Kobilka, Nobel Prize in 
Chemistry 2012) [76]. A signal starts with a ligand bonding to the G-protein coupled 
receptor (GPCR). This consists of seven α-helical peptides that span the membrane 
bilayer. The receptor is located at the outside of the membrane. This binding of a 
ligand to a GPCR induces a conformational change of the GPCR helical membrane 
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complex. This is sensed and influences a G-protein, which can be located at a short 
distance from the receptor. The G-protein is heterotrimeric, with an α-region, a β-
region and a γ-region. All three are reversibly associated components. The binding of 
the receptor induces dissociation of the α-unit with one anchor to the inside of the 
bilayer from the β-unit and γ-unit, which also has a similar anchor into the bilayer 
layer inside.  
This binding also induces a transition at the α-protein of guanisine triphosphate 
(GTP) into the diphosphate (GDP), which in turn via membrane-bound enzymes 
results in the release of second messengers (for example diglycerides) to the target 
cells. In this way one ligand binding to a GPRC can result in a signal cascade 
involving hundreds of target cells! 
Adrenalin, which induces “fight-or-fly” physiological reactions, is one example [77]. 
Other examples of signaling addressing the GPCRs are histamine, seretonin and 
dopamine. Almost half of the number of drugs known at present function via this G-
protein system. 
 
4.3.2. Physiology of the Olfactory System and of Pheromone Activity 
We consider the olfactory system specifically to illustrate this signaling system.  
With mammals, the receptors for smell and pheromone recognition are located 
together in the upper region of the nasal cavity. In primates there is a special region 
for pheromone receptors located near to the receptors for the sense of smell; the 
vomeronasal glands. In other mammals the pheromone receptors are located within 
the olfactory receptor region. The olfactory receptor system in humans covers about 4 
cm2. We can differentiate between about 30,000 – 40,000 different smell identities by 
the olfactory cells and their GPCRs located in the mucous surface [78]. These cells 
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are in fact neurons ending in the region of the cortex allocated to smell. For 
pheromones the signals end in the limbic system of the brain. 
The significance of pheromones for humans is open, but their role in other 
mammalians is well known. They are specialized, for sexual signals. In mice they 
have been shown to inhibit inbreeding. The receptors for pheromones in insects are 
located at the surface of their antennae. They are extremely sensitive. 
Electrophysiological measurements show that a single pheremone molecule can 
induce a signal. 
This is reminiscent of light detection where a single photon is enough to trigger 
reception via rods and cones [79]. A sensitivity so universal must involve cooperative 
transitions of the lipid matrix. Even some single celled eucaryotes have eye-like 
structures called “oecelloids” [80]. 
The influence of salts in the Hofmeister series on the prototypical G-protein visual 
receptor rhodopsin and subsequent work reinforces this universality [79]. 
 
4.3.3. A Problem with Pheromones 
 The triggering of a lipid phase transition like that described for conduction of the 
nerve impulse seems to provide a generic cooperative mechanism. This is so from 
vision to brain function and pheromones and anaesthesia.  
One still insuperable difficulty remains: It is well known that insects can sense sex 
pheromones at incomprehensibly low concentrations. The signals can be triggered by 
direct adsorption of a receptor molecule to the receptor site. And the consequent 
biochemistry and phase change triggered off is well explored.  
The difficulties are: How is the species dependent pheromone molecule information 
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transferred to the initial receptor protein on the antenna? All pheromones are more or 
less simple molecules and van der Waals (visible frequencies) adsorption energies 
will be virtually identical. All differences lie in the infra red region. 
It is possible for the pheromone to be emitted in a metastable excited state. Then long 
range information exchange is possible via photon transfer between a metastable state 
to excite the receptor protein conformation change [11]. 
In a recent study we investigated the effect of the pheromone “olean” (1,7-
dioxaspiro[5.5]undecane, one of the sex pheromones of the olive fly) by bilayers of 
dioleoyl-phosphatidylcholine (DOPC). The results indicated that the uptake of the 
active molecule induces two phase transitions in the the phospholipid dispersion: one 
from lamellar Lα to inverse hexagonal HII and then to inverse cubic III phase. 
Moreover the phase changes reduce the water reorientational motions and lower the 
freezing temperature of water [9]. This is another example of a phase transition – 
induced by hydrophobic adsorption and curvature change - being involved in a 
complex biological mechanism.  
 
4.4. The Prostaglandins  
Two different kinds of lipid have important physiological effects, prostaglandins and 
estolides. They are complex fatty acids with hydroxyl groups attached to the acyl 
chains. Their importance is unquestioned. They must have structural effects on the 
hydrophobic interior of membranes. What those effects are is unexplored. 
The first group are prostaglandins. There are two kinds, called PGE2 and PGF2α. They 
derive from arachidonic acid and contain 20 carbon atoms and a cyclopentane ring in 
the middle region. The detailed chemical structure is classified into groups A to H, 
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according to the type of ring structure, and the number of double bonds. The first 
crystal and molecular structure determination that revealed the architecture of 
prostaglandins were determined by Sixten Abrahamsson in the 1960s [81]. 
They have hormone-like effects. But their applications in medicine are still limited as 
they act in very diverse ways. Some expand the bronchial channels of the lung. Others 
contract them. Some lower the blood pressure. Others increase it.  
The other group are the estolides. Recently it was reported that these molecules 
exhibit a drastic effect on appetite and therefore on obesity [82]. The molecules are 
linked hydroxy-fatty acids, in which the hydroxyl group in one chain is ester-linked to 
a fatty acid carboxyl group in another fatty acid. If this also is a hydroxy-fatty acid, 
molecules with three or four chains may be formed. Such large complexes have been 
shown to exist in oat cereal lipids [83]. Oats are unique in this respect due to their 
content of a hydroxy-fatty acid termed avena-acid. Eat your porridge.  
 
 4.5. A comment on air dissolved in oils 
In surface and colloid science a mineral oil is often considered as similar to a 
triglyceride oil. But one important aspect of the behaviour of an “oil” phase is its 
content of dissolved air. A mineral oil can solvate almost 10% of its volume of air, 
whereas only something in the range between 30 and 40 mg/kg has been reported for 
olive oil and palm oil [84]. Due to the high solubility in mineral oil it should be of 
interest to know the difference in air solubility between pure paraffins of different 
chain lengths. Furthermore, we recall that - due to the very low intermolecular forces 
- perfluorinated oils dissolve an incredible amount of gases [31,32,85]. 
The mapping work by Fontell, Ekwall and Mandell of the system decanol, sodium 
caprylate, water is also interesting to consider in this respect. The decanol-corner-
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located L2 phase is often regarded as an oil corner. What are the effects there of 
dissolved air? And in this connection the remarkable works on enhanced oil solubility 
in degassed water [86], on the variation of the cloud point of dioctanoyl-
phosphatidylcholine upon removal of dissolved gases from its water dispersions [87], 
and on the kinetics of formation of pseudopolyrotaxanes from cyclodextrins [88]. 
Long range “hydrophobic” interactions disappear on removal of dissolved gas, effects 
of which are ignored in classical physical chemistry [75,89]. The implications are 
large and have hardly been recognised. 
 
5 Cubic Bilayer Vesicles, Exosomes, and Cubosomes. 
New liquid-crystalline phases of lipids emerged in the 1960s [90]. The structures 
involved bicontinuous cubic phases. This opened up new perspectives. The real 
structures, vigorously misinterpreted by the Luzzatti School for 40 years held up 
developments. Similarly Fontell had often observed cubic phases 20 years earlier, and 
forbidden to publish them by Ekwall [K. Larsson and B.W. Ninham, private 
communication]! 
Liquid-like disorder for hydrocarbon chains in these phases is too simplistic for 
biology. Cholesterol has a key role. It induces local order. At high concentration it 
causes inhomogeneity due to microphase segregation with consequences as above. 
Membrane-embedded proteins are furthermore localized at the inner side of the 
bilayer, a consequence of lipid membrane asymmetry due to packing constraints (Part 
1). The same packing constraints led to the universality of periodic minimal surface 
conformations in amphiphile-water systems [3,11,75]. 
We have explored some physiological consequences of this wider class of lipid 
geometries. 
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Further conceptual developments, the consequences of which have not been known 
and not explored at all, are embodied in Section 2.3 of Part 1. The necessary 
asymmetry in disposition of lipids between the outer, and the inner surface of any 
vesicle or curved membrane (see Figures 2 and 3 in Ref. 1) in even a single 
component vesicle was proven quite generally in 1981 by one of us and D.J. Mitchell 
and forgotten [91]. This realisation invalidates a great deal of theoretical work on 
vesicles that assume the hydrocarbon chain region of bilayer is symmetric. The 
hydrocarbon chains of lipids on the inside of a curved bilayer necessarily have reverse 
curvature (splayed configuration). The lipids on the outside have normal curvature. 
That has consequences for transmembrane protein disposition and packing across 
membranes, that favour the inner layer.  
It follows from this that prostaglandins and estolides with their small head groups will 
pack on the inner side of vesicles and interact strongly with transmembrane proteins 
to affect their activity. How they do so is obviously specific depending on chain 
length, flexibility and polarity. That observation may be sufficient to explain the 
variable activities they induce (Section 4.6) A similar geometric physical packing 
effect will affect the disposition of lipids like phosphatidyl serine that has not yet been 
studied. 
A major conceptual development is embodied in the phenomenon of supraaggregation 
as an equilibrium and necessary state of aggregation. This was explored in Part 1 Sec. 
2. with implications too wide to include here. 
With those remarks noted, we continue.  
 
5.1. Exosomes  
An isolated vesicle that contains a cubic lipid bilayer will be surrounded and protected 
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by a few asymmetric bilayers in a high state of stress. See discussion of 
supraaggregation (see Part 1). The vesicle will then be very fusogenic, and ideally 
poised for the intensive exchange of materials from a cell and its outside. Endocytosis 
and exocytosis are activities of living cells. It is trite to say that are governed by and 
respond to strict concentration levels, external and internal physico-chemical 
conditions that are the source and sink that drives their self assembly. The intensive 
research going on on exosomes and their function ignores lipid self assembly. To 
explore such arcana, see Refs. 92-94. 
 
5.2. Cubosomes  
Cubosomes in cells were discovered by one of us (KL). It is a word that now labels 
colloid dispersions of cubic bicontinuous phases in water. They are very much in 
vogue, e.g. for thermo-responsive and targeting formulations in drug delivery [95]. 
 
6. Conclusions. A Muddled Progress  
Our conclusions to the analysis of Part 1 holds equally for this Part 2. 
Over the past 40 years lipids, previously almost invisible background to the proteins 
and biopolymers, have emerged as central players. The states of self assembly 
accessible and their supporting roles were non existent. What is satisfying is that these 
new states emerge from a combination of indisputable local packing constraints due 
to opposing interfacial forces, and global packing constraints only. These 
renormalised variables emerge from detailed statistical mechanics and are parameter 
free. The necessary asymmetry of curved membranes and vesicles, supraaggregation, 
cubic phases bring a certain unity and simplicity that cuts through some very 
complicated biological problems. 
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But progress is muddled. On the other side of the coin the complementary face of 
physical chemistry has been evolving fast on molecular forces, Hofmeister effects and 
hydration, the role of dissolved gas, on “hydrophobic” interactions, pH, buffers, and 
more [1,3,75,89,96]. 
The consequence is that the fundamentals and intuition deriving from them are 
subject to major revision [75]. 
Yet biological theories e.g. Hodgkin Huxley equations and “ion pumps” had 
inevitably built on the older classical and invalid theories of physical chemistry, - the 
double layer and electrochemistry, membrane potentials, pH buffers, ion binding and 
transport, zeta potentials - the list is finite but long. Much progress in biology relied 
on measurements that depend, for their interpretation on a flawed theory of physical 
chemistry. The observation means that just as the intuition in physical chemistry has 
to undergo revision, so too will some of the biological intuition that we presently hold 
indisputable. 
There is more. Hot air bubble columns have shown that beyond the still inexplicable 
behavior of bubble- bubble interactions, the reactivity of gas bubbles is amazingly and 
unexpectably catalytic [97]. They kill cells and viruses with extreme efficiency. 
We believe we have made some progress in the spirit of D’Arcy Thompson’s plea. 
There is more to do and the road for young scientists is more open now than ever. 
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